fda approves first oral glp-1 obesity drug august 21 2025 first-ever GLP-1RA for and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/news-releases/fda-approves -novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults Novo Nordisk's weight-loss pill wins

Clear, Juice-Like TextureMixes easily into a refreshing, light drinkperfect for those who dislike thick, milky shakes

Hydroxy B12 shots will be safer

Swanson L-Leucine delivers a potent 500 mg per serving from vegan-sourced AjiPure pharmaceutical grade L-leucine

In 2024 Blue Cross Blue Shield of Michigan informed members and physicians about a change in coverage for GLP-1s.On the surface, GLP-1s promise weight loss, lower blood pressure and a reduced risk of heart and kidney disease, according to the Cleveland Clinic

- Decreased recovery time after workouts (or surgery)

Symptoms of severe vitamin B12 deficiency can include visual disturbances, severe joint pain, paresthesia (tingling in the hands and feet), memory problems, depression, anxiety, poor muscle function, ataxia (impaired balance and coordination), changes in reflexes and even infertility